Researcher leverages Codex and ChatGPT to discover new antimicrobials
| Source: OpenAI | Original article
A researcher leverages Codex and ChatGPT to mine living and extinct genomes for antimicrobial candidates to combat drug‑resistant infections.
César de la Fuente’s laboratory has begun mining both contemporary and extinct genomes with the help of OpenAI’s Codex and ChatGPT, aiming to uncover novel antimicrobial molecules that could counter the rise of drug‑resistant infections. By prompting the language models to generate and evaluate protein‑coding sequences, the team screens vast genetic archives for compounds that display antibacterial activity, then narrows the list to candidates suitable for synthesis and laboratory testing.
The approach matters because traditional antibiotic discovery has stalled while resistance spreads, creating an urgent need for new classes of drugs. Leveraging generative AI accelerates the early‑stage search, allowing researchers to explore evolutionary niches that were previously inaccessible or too costly to probe manually. If successful, the method could reshape how biotech firms and academic labs prioritize targets, shortening the pipeline from hypothesis to pre‑clinical candidate.
The next steps will focus on experimental validation of the AI‑suggested molecules, assessing their efficacy and safety in vitro and in animal models. Observers will watch for peer‑reviewed results that confirm whether the computational hits translate into real‑world antimicrobial activity. Parallel developments—such as regulatory frameworks for AI‑generated biotherapeutics and the emergence of similar AI‑driven discovery platforms—will determine how quickly the technique moves from proof‑of‑concept to a mainstream tool in the fight against antimicrobial resistance.
Sources
Back to AIPULSEN